Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05826743

Safety and Effectiveness Evaluation of the COLO-BT as an Alternative Treatment to the Ileostomy

Safety and Effectiveness Evaluations of the COLO-BT™ (Colorectal Balloon Tube) as an Alternative Treatment to the Temporary Ileostomy Following Proctectomy

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
256 (estimated)
Sponsor
JSR Medical Co., Ltd. · Industry
Sex
All
Age
19 Years – 80 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the Colorectal Balloon Tube (hereinafter referred to as COLO-BT™) device, a single use, temporary intraluminal bypass device, intended to reduce contact of fecal content with an anastomotic site, following colorectal surgery (open or laparoscopic)

Detailed description

A primary diverting stoma is widely used by surgeons in order to bypass low rectal anastomosis and reduce morbidity associated with anastomotic leaks. Typically, a stoma is created for all high-risk patients which mean that many patients are exposed to potentially serious complications associated with the stoma itself without any clinical benefit. COLO BT™ is a local, temporary bypass device that provides protection of the anastomosis and safely postpones stoma. COLO BT™ is designed to avoid stoma creation in all patients except those patients whose anastomoses have not healed after surgery, allowing the others to return to normal activity more quickly and safely.

Conditions

Interventions

TypeNameDescription
DEVICECOLO BT™A removable, temporary intraluminal bypass device designed to safely postpone the creation of a protective stoma after surgery for only patients who need it (do not have a healed anastomosis)
OTHERStoma CreationProtective ileostomy

Timeline

Start date
2023-12-04
Primary completion
2026-12-15
Completion
2027-03-15
First posted
2023-04-24
Last updated
2025-06-13

Locations

3 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT05826743. Inclusion in this directory is not an endorsement.